Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Ryunosuke Saiki et al.|Nature Medicine|2020Cited by 633
Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasmsHideki Makishima, Jaroslaw P. Maciejewski, Ryunosuke Saiki et al.|Blood|2022Cited by 142
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11Yuichi Ishikawa, Hitoshi Kiyoi, Naomi Kawashima et al.|Blood Advances|2020Cited by 127
Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor Vβ Clonality Predict Treatment-Free Remission After Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring StudyTatsuro Jo, Toru Kiguchi|International Journal of Molecular Sciences|2026Cited by 1